NS5A: A new target for antiviral drugs in the treatment of hepatitis C virus infection

被引：6
|
作者：
Debes, Jose D. [1 ]
Smith, Coleman I. [1 ]
机构：
[1] Univ Minnesota, Plymouth, MN USA
来源：
HEPATOLOGY | 2012年 / 56卷 / 03期
关键词：
GENOTYPE; 1; PROTEIN; REPLICATION; INHIBITOR; BMS-790052;
D O I：
10.1002/hep.25696
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：797 / 799
页数：3
相关论文
共 50 条
  • [21] Hepatitis C virus NS5A: tales of a promiscuous protein
    Macdonald, A
    Harris, M
    JOURNAL OF GENERAL VIROLOGY, 2004, 85 : 2485 - 2502
  • [22] The Prevalence of Hepatitis C Virus NS5A Polymorphisms in Europe
    Popping, Stephanie
    Cento, Valeria
    Boucher, Charles A.
    Wensing, Annemarie
    Devaux, Carole
    Rijnders, Bart
    Parczewski, Milosz
    Urbanska, Anouk
    Poljak, Mario
    Lunar, Maja
    De Salazar, Adolfo
    Aragrig, Marianna
    Van de Vijver, David
    Garcia, Federico
    Ceccherini-Silberstein, Francesca
    HEPATOLOGY, 2018, 68 : 923A - 924A
  • [23] In Vitro and In Vivo Antiviral Activity and Resistance Profile of Ombitasvir, an Inhibitor of Hepatitis C Virus NS5A
    Krishnan, Preethi
    Beyer, Jill
    Mistry, Neeta
    Koev, Gennadiy
    Reisch, Thomas
    DeGoey, David
    Kati, Warren
    Campbell, Andrew
    Williams, Laura
    Xie, Wangang
    Setze, Carolyn
    Molla, Akhteruzzaman
    Collins, Christine
    Pilot-Matias, Tami
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (02) : 979 - 987
  • [24] In Vitro Antiviral Activity and Resistance Profile Characterization of the Hepatitis C Virus NS5A Inhibitor Ledipasvir
    Cheng, Guofeng
    Tian, Yang
    Doehle, Brian
    Peng, Betty
    Corsa, Amoreena
    Lee, Yu-Jen
    Gong, Ruoyu
    Yu, Mei
    Han, Bin
    Xu, Simin
    Dvory-Sobol, Hadas
    Perron, Michel
    Xu, Yili
    Mo, Hongmei
    Pagratis, Nikos
    Link, John O.
    Delaney, William
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (03) : 1847 - 1853
  • [25] Grazoprevir, Ruzasvir, and Uprifosbuvir for Hepatitis C Virus After NS5A Treatment Failure
    Wyles, David
    Wedemeyer, Heiner
    Ben-Ari, Ziv
    Gane, Edward J.
    Hansen, Jesper Bach
    Jacobson, Ira M.
    Laursen, Alex L.
    Luetkemeyer, Annie
    Nahass, Ronald
    Pianko, Stephen
    Zeuzem, Stefan
    Jumes, Patricia
    Huang, Hsueh-Cheng
    Butterton, Joan
    Robertson, Michael
    Wahl, Janice
    Barr, Eliav
    Joeng, Hee-Koung
    Martin, Elizabeth
    Serfaty, Lawrence
    HEPATOLOGY, 2017, 66 (06) : 1794 - 1804
  • [26] Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon
    Shimakami, T
    Hijikata, M
    Luo, H
    Ma, YY
    Kaneko, S
    Shimotohno, K
    Murakami, S
    JOURNAL OF VIROLOGY, 2004, 78 (06) : 2738 - 2748
  • [27] Ser235 phosphorylation of hepatitis C virus NS5A is required for NS5A dimerization and drug resistance
    Lee, Wei-Ping
    Tsai, Keng-Chang
    Liao, Shi-Xian
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    Lan, Keng-Hsin
    LIFE SCIENCES, 2024, 337
  • [28] Insights into the Complexity and Functionality of Hepatitis C Virus NS5A Phosphorylation
    Ross-Thriepland, Douglas
    Harris, Mark
    JOURNAL OF VIROLOGY, 2014, 88 (03) : 1421 - 1432
  • [29] Hepatitis C virus NS5A inhibitors and drug resistance mutations
    Nakamoto, Shingo
    Kanda, Tatsuo
    Wu, Shuang
    Shirasawa, Hiroshi
    Yokosuka, Osamu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (11) : 2902 - 2912
  • [30] Looking at the Molecular Target of NS5A Inhibitors throughout a Population Highly Affected with Hepatitis C Virus
    Ramos, Diogo
    Pinto, Miguel
    Coutinho, Rodrigo Sousa
    Silva, Carolina
    Quina, Miriam
    Gomes, Joao Paulo
    Padua, Elizabeth
    PATHOGENS, 2023, 12 (06):
12345